LDL-Apheresis Removes Serum Amyloid P and A in Hypercholesterolemic Patients

Author： Palumbo B.   Cardinali L.   Sinzinger H.  

Publisher： Elsevier

ISSN： 0049-3848

Source： Thrombosis Research, Vol.97, Iss.6, 2000-03, pp. : 491-494

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Ex-vivo and in-vivo platelet function in patients with severe hypercholesterolemia undergoing LDL-apheresis

By Sinzinger H.   Pirich C.   Bednar J.   O'Grady J.  

Thrombosis Research, Vol. 82, Iss. 4, 1996-05 ,pp. : 291-301

Elsevier

Access to resources Recommend Favorite

Angiotensin Receptor Antagonists During Dextran Sulfate LDL-Apheresis Are Safe

By Sinzinger H.   Chehne F.   Ferlitsch A.   Oguogho A.  

Thrombosis Research, Vol. 100, Iss. 1, 2000-10 ,pp. : 43-46

Elsevier

Access to resources Recommend Favorite

Increased serum levels of granulocyte-macrophage colony-stimulating factor in hypercholesterolemic patients

By Parissis J.T.   Venetsanou K.F.   Mentzikof D.G.   Kalantzi M.V.   Karas S.M.  

European Journal of Internal Medicine, Vol. 10, Iss. 3, 1999-12 ,pp. : 146-149

Elsevier

Access to resources Recommend Favorite

Elevated Serum Total and LDL Cholesterol in Very Old Patients with Alzheimer’s Disease

By  

Dementia and Geriatric Cognitive Disorders, Vol. 12, Iss. 2, 2001-02 ,pp. : 138-145

Karger

Access to resources Recommend Favorite

Serum Amyloid P Component as a Biomarker in Mild Cognitive Impairment and Alzheimer’s Disease

By  

Dementia and Geriatric Cognitive Disorders, Vol. 26, Iss. 6, 2008-12 ,pp. : 522-527

Karger

Access to resources Recommend Favorite